Effect of photodynamic doses of laser irradiation on endogenous intoxication indices
DOI:
https://doi.org/10.31288/oftalmolzh201543537Keywords:
photodynamic therapy, endogenous intoxication, middle-weight molecules (MWM)Abstract
Background: One of the promising areas in ophthalmology is photodynamic therapy (PDT).
Purpose: To assess the effect of laser irradiation of the rat eye at the doses applied in PDT (without photosensitizer) on endogenous intoxication indices.
Materials and Methods: Fifty rats were used to investigate the effect of different modes of photodynamic irradiation of the rat eye on changes in endogenous intoxication indices over time.
Results: Exposure to 630-nm laser irradiation of 300-mJ pulsed mode (3 min) and 60-J photodynamic dose (PDD) mode (15 s) does not result in the development of endogenous intoxication. According to the literature, serum level of middle-weight molecules (MWM) is an integral marker of metabolic disorders of the body and can be used as evidence of the intensity of endogenous intoxication.
Conclusion: Exposure to 630-nm laser irradiation of 300-mJ pulsed mode (3 min) and 60-J PDD mode (15 s) does not result in the development of endogenous intoxication, making possible the application of these modes in practical ophthalmology. Because exposure to 890-nm laser irradiation of 300-mJ pulsed mode (3 min), and, especially, to 630-nm laser irradiation of 120-J PDD mode (30 s) results in the increased accumulation of MWM in circulating blood of animals, the eye should not be exposed to such irradiation doses.
References
1. Volodin PL. [Photodynamic therapy with chlorin photosensitizer in ophthalmology (experimental and clinical study)]. [Dr. Sc. (Med.) thesis]. Obninsk (Russia): Medical Radiological Research Center of RAMS; 2009. 265 p. Russian.
2. Gelfond ML, Arseniev AI, Levchenko EV et al. [Photodynamic therapy in complex treatment of malignant tumors: current state and future prospects]. Laser Med. 2012;16(2):25-30. Russian.
3. Samlin RM, Sten'ko AA, Zhuk IG, Bragov MIu. [Main areas of photodynamic therapy in medicine]. NovKhir. 2008;3:155-162.
4. Takhchidi HP, Bely? IuA, Tereshchenko AV et al. [Photodynamic therapy in ophthalmology (review)]. Oftalmokh. 2005; 1:45-51. Russian.
5. Nazyrov FG, Sadykov RA, Mirzakulov A, Sadykov RR. [Potential and prospects of photodynamic therapy for tumors]. Uzb Med J. 2010;2:55-8. Russian.
6. Sadykov RA, Kasymov KR, Sadykov RR. [Technical and scientific aspects of photodynamic therapy]. Tashkent;2012. 167 p.
7. Korochkin IM, Chukaeva Sh.I. [Determination of serum levels of middle molecule peptides in patients with acute myocardial infarction]. Lab Delo. 1988;9:15-8. Russian.
8. Kariakina EV, Belova SV. [Middle-weight molecules as an integral marker of metabolic disorders (literature review)]. Clin Lab Diagn. 2004;3:3-8. Russian.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Ф. А. Бахритдинова, К. И. Нарзикулова, С. Ш. Миррахимова
This work is licensed under a Creative Commons Attribution 4.0 International License.
This work is licensed under a Creative Commons Attribution 4.0 International (CC BY 4.0) that allows users to read, download, copy, distribute, print, search, or link to the full texts of the articles, or use them for any other lawful purpose, without asking prior permission from the publisher or the author as long as they cite the source.
COPYRIGHT NOTICE
Authors who publish in this journal agree to the following terms:
- Authors hold copyright immediately after publication of their works and retain publishing rights without any restrictions.
- The copyright commencement date complies the publication date of the issue, where the article is included in.
DEPOSIT POLICY
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) during the editorial process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work with an acknowledgement of its initial publication in this journal.
- Post-print (post-refereeing manuscript version) and publisher's PDF-version self-archiving is allowed.
- Archiving the pre-print (pre-refereeing manuscript version) not allowed.
